We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
-1.56%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.45B
AUM Growth
-$851M
Cap. Flow
-$617M
Cap. Flow %
-9.57%
Top 10 Hldgs %
23.85%
Holding
3,274
New
30
Increased
484
Reduced
2,296
Closed
55

Top Sells

Rank Stock Value
1
RJF icon
Raymond James Financial
RJF
+$97M
2
HSY icon
Hershey
HSY
+$93.2M
3
MCHP icon
Microchip Technology
MCHP
+$92.3M
4
GPN icon
Global Payments
GPN
+$29.9M
5
MRK icon
Merck
MRK
+$29.2M

Sector Composition

Rank Sector Weight
1 Technology 21.55%
2 Financials 17.86%
3 Healthcare 13.05%
4 Industrials 9.07%
5 Consumer Discretionary 8.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVVD icon
2801
Invivyd
IVVD
$245M
$828 ﹤0.01%
1,368
-1,326
-49% -$1.19K
GPGI
2802
GPGI Inc
GPGI
$3.59B
$826 ﹤0.01%
76
-79
-51% -$969
HROW icon
2803
Harrow
HROW
$1.27B
$825 ﹤0.01%
31
GYRE icon
2804
Gyre Therapeutics
GYRE
$709M
$818 ﹤0.01%
106
-110
-51% -$1.21K
MAZE
2805
Maze Therapeutics
MAZE
$1.35B
$815 ﹤0.01%
+74
New +$891
AXGN icon
2806
Axogen
AXGN
$2.42B
$814 ﹤0.01%
44
AGNT
2807
AGNT Inc
AGNT
$648M
$812 ﹤0.01%
83
RDNW
2808
RideNow Group
RDNW
$220M
$812 ﹤0.01%
288
-257
-47% -$1.06K
AMPL icon
2809
Amplitude
AMPL
$1.67B
$805 ﹤0.01%
79
CDRE icon
2810
Cadre Holdings
CDRE
$1.18B
$799 ﹤0.01%
27
BLND icon
2811
Blend Labs
BLND
$322M
$797 ﹤0.01%
238
XERS icon
2812
Xeris Biopharma Holdings
XERS
$1.37B
$780 ﹤0.01%
142
ML
2813
DELISTED
MoneyLion Inc.
ML
$779 ﹤0.01%
9
UDMY
2814
DELISTED
Udemy
UDMY
$776 ﹤0.01%
100
LUNG icon
2815
Pulmonx
LUNG
$82M
$774 ﹤0.01%
115
GRC icon
2816
Gorman-Rupp
GRC
$1.88B
$772 ﹤0.01%
22
ICLO icon
2817
Invesco AAA CLO Floating Rate Note ETF
ICLO
$577M
$765 ﹤0.01%
30
XPEL icon
2818
XPEL
XPEL
$1.27B
$764 ﹤0.01%
26
OEC icon
2819
Orion
OEC
$328M
$763 ﹤0.01%
59
ARRY icon
2820
Array Technologies
ARRY
$675M
$755 ﹤0.01%
155
ABOS icon
2821
Acumen Pharmaceuticals
ABOS
$209M
$754 ﹤0.01%
685
-740
-52% -$1.06K
NAUT icon
2822
Nautilus Biotechnolgy
NAUT
$113M
$753 ﹤0.01%
875
-780
-47% -$1.16K
PRPL icon
2823
Purple Innovation
PRPL
$12.4M
$745 ﹤0.01%
39
-37
-49% -$853
AVDL
2824
DELISTED
Avadel Pharmaceuticals
AVDL
$744 ﹤0.01%
95
PRSU
2825
Pursuit Attractions and Hospitality Inc
PRSU
$1.34B
$743 ﹤0.01%
+21
New +$820

Similar funds

Sterling Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Sterling Capital Management held 3,274 positions worth $6.45B, down 12% from $7.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Sterling Capital Management withdrew a net $617M in Q1 2025, closing 55 positions and reducing 2,296 holdings. Its most notable exit was WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock, an estimated $4.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in Samsara worth $2.79M.

  • Sterling Capital Management's largest Q1 2025 buy was Samsara: 72,827 shares worth $2.79M.
  • Sterling Capital Management added most to Linde in Q1 2025, an estimated $102M increase.
  • Sterling Capital Management's biggest Q1 2025 reduction was Raymond James Financial, cutting an estimated $97M.
  • Sterling Capital Management fully exited WESCO International, Inc. Depositary Shares each representing 1/1,000th interest in a share of Series A Fixed-Rate Reset Cumulative Perpetual Preferred Stock in Q1 2025, selling an estimated $4.77M.
  • Sterling Capital Management's ten largest holdings make up 24% of its $6.45B portfolio in Q1 2025.
  • Sterling Capital Management opened 30 new positions and closed 55 in Q1 2025.
  • Sterling Capital Management's portfolio value fell 12% quarter-over-quarter to $6.45B.

Based on Sterling Capital Management's 13F filing for Q1 2025, filed 13 May 2025.